ArTS Archivio della ricerca di Trieste

STOLFO, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.071
EU - Europa 8.627
AS - Asia 7.270
SA - Sud America 992
Continente sconosciuto - Info sul continente non disponibili 762
AF - Africa 234
OC - Oceania 20
Totale 29.976
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.719
IT - Italia 3.917
SG - Singapore 2.617
CN - Cina 1.693
PL - Polonia 1.100
VN - Vietnam 754
BR - Brasile 733
HK - Hong Kong 645
DE - Germania 567
SE - Svezia 555
FR - Francia 414
BD - Bangladesh 412
NL - Olanda 370
KR - Corea 359
GB - Regno Unito 334
RU - Federazione Russa 298
FI - Finlandia 241
IN - India 182
CA - Canada 178
UA - Ucraina 137
IE - Irlanda 132
BG - Bulgaria 128
TR - Turchia 90
MX - Messico 88
JP - Giappone 86
AT - Austria 78
AR - Argentina 76
ES - Italia 73
MA - Marocco 64
ID - Indonesia 62
ZA - Sudafrica 53
CH - Svizzera 50
IQ - Iraq 48
PK - Pakistan 47
BE - Belgio 43
CO - Colombia 37
EC - Ecuador 36
VE - Venezuela 32
GR - Grecia 30
SA - Arabia Saudita 30
CL - Cile 28
PE - Perù 28
RO - Romania 27
EG - Egitto 25
SN - Senegal 25
IR - Iran 24
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
PH - Filippine 19
PT - Portogallo 19
MY - Malesia 18
AU - Australia 17
CR - Costa Rica 16
DZ - Algeria 16
NP - Nepal 16
JO - Giordania 14
CZ - Repubblica Ceca 13
LT - Lituania 13
TW - Taiwan 13
HU - Ungheria 12
IL - Israele 12
JM - Giamaica 12
TH - Thailandia 12
OM - Oman 11
DK - Danimarca 10
KE - Kenya 10
KZ - Kazakistan 10
PY - Paraguay 10
TT - Trinidad e Tobago 10
LV - Lettonia 9
RS - Serbia 9
TN - Tunisia 9
AL - Albania 8
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
UY - Uruguay 8
EU - Europa 7
HN - Honduras 7
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
GT - Guatemala 6
NO - Norvegia 6
BH - Bahrain 5
BY - Bielorussia 5
LK - Sri Lanka 5
LU - Lussemburgo 5
SY - Repubblica araba siriana 5
BO - Bolivia 4
PA - Panama 4
PS - Palestinian Territory 4
SI - Slovenia 4
TG - Togo 4
BB - Barbados 3
BS - Bahamas 3
CG - Congo 3
CY - Cipro 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
HR - Croazia 3
Totale 29.157
Salva come PNG Salva come JPEG
Città #
Ashburn 1.709
Singapore 1.531
Warsaw 938
Fairfield 779
San Jose 757
Chandler 746
Hong Kong 621
Council Bluffs 466
Woodbridge 465
Trieste 427
Houston 391
Milan 386
Beijing 374
Seoul 343
Seattle 338
Hefei 335
Ann Arbor 319
Wilmington 289
Los Angeles 275
Rome 273
Cambridge 246
Chicago 226
Ho Chi Minh City 223
Boardman 203
Dallas 199
Columbus 182
New York 182
Naples 169
Santa Clara 169
Princeton 165
Hanoi 158
Lauterbourg 146
London 139
Helsinki 138
Jacksonville 126
Sofia 125
Dublin 119
Zgierz 119
Frankfurt am Main 108
Moscow 108
The Dalles 100
Buffalo 95
São Paulo 89
Munich 85
Phoenix 80
Turin 75
Dearborn 62
Amsterdam 61
Atlanta 61
Tokyo 57
Toronto 57
Bologna 55
Düsseldorf 53
Florence 52
Izmir 48
Denver 47
San Diego 47
Nuremberg 46
Montreal 45
Orem 45
Vienna 45
Grafing 44
Shanghai 44
Casablanca 42
Da Nang 42
Lappeenranta 42
Catania 41
Genoa 41
Guangzhou 40
North Bergen 40
Washington 40
Brussels 39
Palermo 39
Memphis 36
Bari 35
Chennai 34
Padova 34
Venice 34
Verona 34
Bremen 32
Haiphong 32
Turku 32
Nanjing 31
Brooklyn 30
Boston 29
Redondo Beach 29
Rio de Janeiro 29
Udine 29
Dong Ket 28
San Francisco 27
Miano 26
Dakar 25
Des Moines 25
Jinan 25
Johannesburg 25
Mykolayiv 25
Pune 25
Redmond 25
Treviso 25
Manchester 24
Totale 17.596
Salva come PNG Salva come JPEG
Nome #
Linee guida sullo scompenso cardiaco a confronto: AHA 2022 versus ESC 2021 2.060
Cardiac fluid dynamics meets deformation imaging 485
Natural History of Dilated Cardiomyopathy in Children 441
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 419
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 416
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 369
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 336
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 333
Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry. 329
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking 309
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine 304
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 285
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 284
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 281
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 281
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 280
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 272
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 271
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 270
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure 267
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 265
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 264
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 264
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases 264
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History 264
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 258
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis 258
Chapter 12: Prognostic Stratification and Importance of Follow-Up 253
Treatment of Functional Mitral Regurgitation in Heart Failure 252
Impact of patient delay in a modern real world STEMI network 252
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy 250
ECG in dilated cardiomyopathy: Specific findings and long-term prognostic significance 250
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 249
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 244
Evolving concepts in dilated cardiomyopathy 243
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 240
Left Atrial Reverse Remodeling in Dilated Cardiomyopathy 239
Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature 239
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 239
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 238
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 237
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 235
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 235
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 233
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 233
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 232
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 231
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 230
Chapter 3: Pathophysiology 226
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 226
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 224
Coronary fistula of the left main artery draining in the right atrium and associated aorto-right atrial fistula 223
Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry 217
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 217
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 212
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 211
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 210
Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis 208
Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 203
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients 199
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 199
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 193
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 191
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy 191
Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives 185
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 185
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 183
Prognostic significance of longitudinal strain in dilated cardiomyopathy with recovered ejection fraction 183
Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction 183
Does extracorporeal cardiopulmonary resuscitation improve survival with favorable neurological outcome in out-of-hospital cardiac arrest? A systematic review and meta-analysis 182
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation 182
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences 181
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 179
Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications 176
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 174
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 174
Heart failure with mid-range or mildly reduced ejection fraction 174
Effect of prehospital treatment in STEMI patients undergoing primary PCI 173
Dilated cardiomyopathy: Dilated cardiomyopathy: Clinical assessment and differential diagnosis 169
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 167
Value of Strain Imaging and Maximal Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy 167
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 167
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 164
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 160
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 159
Impaired Right Ventricular Longitudinal Strain Without Pulmonary Hypertension in Patients Who Have Recovered From COVID-19 158
Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy 157
Using marginal structural joint models to estimate the effect of a time-varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy 156
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 156
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring with Arrhythmic Risk in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy 156
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 152
A very rare cause of pre-capillary pulmonary hypertension: The PAMI syndrome 152
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 148
The Arrhythmic Phenotype in Cardiomyopathy 145
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 145
Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis 145
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension 143
Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications 143
In-hospital evolution of secondary mitral regurgitation in acutely decompensated heart failure 142
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator 139
Totale 24.437
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.779
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.203 0 0 67 75 85 125 63 43 137 142 136 330
2022/20233.242 188 291 294 420 270 415 151 291 314 150 287 171
2023/20242.484 204 161 169 220 213 266 390 303 63 108 242 145
2024/20254.565 113 207 385 397 406 354 233 262 577 674 446 511
2025/202611.369 1.090 672 807 1.073 956 884 1.413 416 1.167 1.458 880 553
2026/20271.745 842 595 308 0 0 0 0 0 0 0 0 0
Totale 29.976